The Claim
In healthy older adults aged 65–90, a three-week open-label placebo intervention is associated with a modest but statistically significant improvement in short-term memory performance (Digit Span) compared to a no-intervention control group, but not compared to a deceptive placebo group.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults aged 65 to 90, openly telling participants they are receiving a placebo improves short-term memory performance on the Digit Span test compared to no treatment, but not compared to a placebo given under deception.
See the scientific wording
In healthy older adults aged 65–90, a three-week open-label placebo intervention is associated with a modest but statistically significant improvement in short-term memory performance (Digit Span) compared to a no-intervention control group, but not compared to a deceptive placebo group, suggesting that transparently disclosed expectations may enhance cognitive function independently of deception.
When a person expects their memory to improve, the front part of the brain sends stronger signals to the memory center, making it easier to hold and recall information for a few seconds.
What the research says
1 studyOlder adults who were told they were taking fake pills that could help memory through the mind-body connection remembered one more digit on a memory test after three weeks, compared to those who got no pills at all—even though they knew the pills weren’t real medicine.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.